<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Sanchez-Mut JV</dc:creator>
  <dc:creator>Heyn H</dc:creator>
  <dc:creator>Silva BA</dc:creator>
  <dc:creator>Dixsaut L</dc:creator>
  <dc:creator>Garcia-Esparcia P</dc:creator>
  <dc:creator>Vidal E</dc:creator>
  <dc:creator>Sayols S</dc:creator>
  <dc:creator>Glauser L</dc:creator>
  <dc:creator>Monteagudo-Sánchez A</dc:creator>
  <dc:creator>Perez-Tur J</dc:creator>
  <dc:creator>Ferrer I</dc:creator>
  <dc:creator>Monk D</dc:creator>
  <dc:creator>Schneider B</dc:creator>
  <dc:creator>Esteller M</dc:creator>
  <dc:creator>Gräff J</dc:creator>
  <dc:date>2018</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The chances to develop Alzheimer's disease (AD) result from a combination of genetic and non-genetic risk factors 1 , the latter likely being mediated by epigenetic mechanisms 2 . In the past, genome-wide association studies (GWAS) have identified an important number of risk loci associated with AD pathology 3 , but a causal relationship remains difficult to establish. In contrast, locus-specific or epigenome-wide association studies (EWAS) have revealed site-specific epigenetic alterations, which provide mechanistic insights for a particular risk gene but often lack the statistical power of GWAS 4 . Here, combining both approaches, we report a previously unidentified association of the peptidase M20-domain-containing protein 1 (PM20D1) with AD. We find that PM20D1 is a methylation and expression quantitative trait locus coupled to an AD-risk associated haplotype, which displays enhancer-like characteristics and contacts the PM20D1 promoter via a haplotype-dependent, CCCTC-binding-factor-mediated chromatin loop. Furthermore, PM20D1 is increased following AD-related neurotoxic insults at symptomatic stages in the APP/PS1 mouse model of AD and in human patients with AD who are carriers of the non-risk haplotype. In line, genetically increasing or decreasing the expression of PM20D1 reduces and aggravates AD-related pathologies, respectively. These findings suggest that in a particular genetic background, PM20D1 contributes to neuroprotection against AD.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/102661</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-018-0013-y</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/29736028</dc:relation>
  <dc:source>Nature medicine. - 2018</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Aged</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Alzheimer Disease</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Amidohydrolases</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Amyloid beta-Peptides</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Cell Line, Tumor</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Chromatin</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Frontal Lobe</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Genome-Wide Association Study</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Hydrogen Peroxide</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Linkage Disequilibrium</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Mice</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Polymorphism, Single Nucleotide</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Quantitative Trait Loci</dc:subject>
  <dc:title xmlns:ns19="xml" ns19:lang="en">PM20D1 is a quantitative trait locus associated with Alzheimer's disease.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
